Jefferies Hosts Voxzogo KOL Call, Reiterates Buy Rating on BioMarin Pharmaceutical Inc's (BMRN)

March 4, 2022 8:20 AM EST Send to a Friend
Jefferies analyst Akash Tewari reiterated a Buy rating and $100.00 price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) after hosting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login